Li Zhuoyu, Fan Daoyang, Zhang Qing, Liu Weifeng
Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
National Center for Orthopedics, Beijing, China.
Int Orthop. 2025 Jan;49(1):271-278. doi: 10.1007/s00264-024-06345-8. Epub 2024 Oct 11.
The proximal humeral reconstruction is challenging. This study aims to investigate the survival, function and complications of clavicla pro humero (CPH) for pediatric proximal humeral reconstruction.
A retrospective cohort study was conducted on eight patients (4 males, and 4 females) who underwent clavicla pro humero reconstruction between January 2009 and December 2020 in our institution. The average age was 10.4 ± 2.7 years (range, 6 to 14 years). The functional outcomes were assessed by the Musculoskeletal Tumor Society Score (MSTS-93), the Toronto Extremity Salvage Score (TESS), the American Shoulder and Elbow Surgeons (ASES) score and the range of motion (ROM) of the shoulder. The complications and overall survivorship of clavicla pro humero were recorded in the follow-up.
The mean follow-up of all patients was 54.6 ± 23.9 months (range, 24 to 84 months) and 73.3 ± 8.5 months (range, 72 to 84 months) in all survivors. All patients had a bone union at an average of 3.8 months after the initial procedure. Only one patient had no complications in the follow-up. The most common complications were clavicle fracture (87.5%, 7/8), followed by pseudarthrosis (62.5%, 5/8), proximal clavicle osteolysis (37.5%, 3/8) and skin flap necrosis (12.5%, 1/8). The average MSTS-93 score was 79% (range, 73-86%), the average TESS was 82% (range, 76-86%) and the average ASES was 70% (68-73%), respectively.
The clavicla pro humero procedure provides rapid bone union but has a high complication rate. Therefore, we do not recommend this technique as a routine surgical procedure for paediatric proximal humeral reconstruction when other methods are available.
level IV therapeutic study.
肱骨近端重建具有挑战性。本研究旨在探讨用于儿童肱骨近端重建的锁骨肱骨术(CPH)的生存率、功能及并发症情况。
对2009年1月至2020年12月在本机构接受锁骨肱骨术重建的8例患者(4例男性,4例女性)进行回顾性队列研究。平均年龄为10.4±2.7岁(范围6至14岁)。通过肌肉骨骼肿瘤学会评分(MSTS - 93)、多伦多肢体挽救评分(TESS)、美国肩肘外科医师(ASES)评分以及肩关节活动范围(ROM)评估功能结果。随访中记录锁骨肱骨术的并发症及总体生存率。
所有患者的平均随访时间为54.6±23.9个月(范围24至84个月),所有存活患者的平均随访时间为73.3±8.5个月(范围72至84个月)。所有患者在初次手术后平均3.8个月实现骨愈合。随访中仅1例患者无并发症。最常见的并发症为锁骨骨折(87.5%,7/8),其次为假关节形成(62.5%,5/8)、近端锁骨骨质溶解(37.5%,3/8)和皮瓣坏死(12.5%,1/8)。MSTS - 93评分平均为79%(范围73 - 86%),TESS平均为82%(范围76 - 86%),ASES平均为70%(68 - 73%)。
锁骨肱骨术可实现快速骨愈合,但并发症发生率较高。因此,当有其他方法可用时,我们不推荐将该技术作为儿童肱骨近端重建的常规手术方法。
IV级治疗性研究。